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Abstract 
Transformation of hamster primary myoblasts with the SV40 large T antigen leads to inhibition of terminal 
differentiation. This process is associated with a block in the transcription of the muscle-specific determinator 
genes MyoD and myogenin. The effect of SV40 large T antigen on the terminal differentiation is dominant and 
cannot be bypassed by re-expression of retrovirally encoded MyoD. The intermediate filament protein desmin is 
normally up-regulated when myoblasts differentiate into myotubes. Surprisingly, desmin is expressed at relatively 
high levels in transformed hamster muscle cells grown under proliferative conditions. So desmin expression can be 
independent of the onset of differentiation. This is in accordance with the expression of the protein in fibroblasts, 
infected with a MyoD-encoding retrovirus and grown under proliferative conditions, when no other muscle-specific 
proteins are present. 
Introduction 
The intermediate filament (IF) protein desmin, which 
is expressed mainly in skeletal muscle, smooth muscle 
and heart, is a very early marker of muscle differen- 
tiation. At day 8.5 in the development of the mouse, 
the protein is expressed in the heart rudiment and at 
day 9.0 post coitum it appears in the myotome [1]. 
During differentiation f cultured skeletal muscle cells 
desmin expression is up-regulated to high levels. A cer- 
tain amount of desmin, however, is already present in 
replicating myoblasts [2, 3]. It has now been well estab- 
lished that desmin expression is regulated by myogenic 
determination factors like MyoD, myogenin, myf-5 
and MRF-4 [4-6]. These experiments have all been 
performed in tissue culture. Despite all the available 
data on expression regulation, the function of desmin 
in differentiated muscle cells in vivo remains totally 
elusive. 
It has been suggested recently that desmin expres- 
sion is a prerequisite for myoblasts to fuse into mult- 
inucleated myotubes [7]. On the other hand several 
reports indicate that ceils expressing a high amount of 
desmin but no MyoD and myogenin are incapable of 
fusion [8, 9]. Lack of fusion and absence of function- 
al MyoD and myogenin has often been observed after 
transfection with oncogenes [10-12] or the addition 
of exogenous growth factors [13, 14]. Also cellular 
transformation by SV40, polyoma and adenoviruses 
has been reported to inhibit terminal differentiation 
[15-19]. 
In the case of SV40 large T antigen conflicting 
results have been reported concerning the inhibito- 
ry effect on terminal differentiation [9, 20]. There- 
fore, we have transfected primary hamster muscle cells 
with a plasmid encoding the large T transcription unit. 
Several resulting clones have been tested for differ- 
entiative abilities in correlation with desmin expres- 
sion. We have found high amounts of desmin protein 
but no myotube formation. Next, the expression of 
the muscle-specific proteins MyoD and myogenin has 
been investigated in some of the cell clones and we 
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were not able to detect heir mRNAs. By infecting a 
representative c ll line with a MyoD encoding virus 
we tried to vercome the negative ffects of the large 
T antigen expression on the terminal differentiation. 
These experiments contribute to a better understand- 
ing of the regulation of desmin expression i relation 
to myogenesis. 
Materials and methods 
Cell culture and DNA transfection 
C2 skeletal muscle myoblast cells [21 ] and transformed 
hamster skeletal muscle cells were grown i  Dulbec- 
co's modified Eagle's medium (DMEM) supplemented 
with 20% fetal calf serum. For induction of myogenic 
differentiation, confluent cultures were switched to low 
serum medium (DMEM with 2% horse serum or 0,4% 
ultroser G). C2 cells are known to fuse within 24 to 36 
h. 
Transformed hamster skeletal muscle cell lines 
were established from thigh muscle tissue from a Syr- 
ian gold hamster [22], Tissue was dissociated and the 
obtained satellite cells were plated into 35-ram tis- 
sue culture dishes (105 cells per dish) in 2 ml growth 
medium containing 20% fetal bovine serum and 2% 
chicken embryo extract [23]. After 24 h cell debris and 
nonadherent cells were removed by washing with Dul- 
becco's modified phosphate-buffered saline (DPBS). 
At this point several cell samples were plated into 100- 
mm dishes (at a density of 0.5 106 cells per dish) for 
transfection with an expression plasmid encoding the 
SV40 large T antigen and a defective SV40 origin of 
replication [24] in order to obtain transformation. Oth- 
er celt samples were plated in DMEM containing 10% 
serum and switched to 2% horse serum later on for 
determination f differentiating capacities. Transfec- 
tion was performed according to a modified calcium 
phosphate precipitation method [25]. After two weeks 
in DMEM with 20% fetal bovine serum and no fur- 
ther supplementations, cell clones containing actively 
growing cells were isolated and expanded. 
Human primary fibroblasts were cultured in 
DMEM supplemented with 10% fetal bovine serum. 
Fibroblasts and tranformed hamster cells were infect- 
ed with a recombinant retrovirus containing the MyoD 
coding sequences under the control of a viral long ter- 
minal repeat promoter [25]. Cells were selected by 
supplementation of geneticin, which is a virus-encoded 
selection marker. After selection, clones were pooled 
and cells were maintained either in standard growth 
medium or in differentiation medium for 48 h. 
RNA isolation and Northern blotting 
RNA from proliferating C2 myoblasts and 3 day post- 
fusion C2 myotubes was isolated by the Li-urea method 
[27], The same procedure has been applied to three 
cell clones obtained after transfection with the SV40 
plasmid, Total RNA samples (10 l~g) were glyoxylat- 
ed, fractionated on 1% agarose gels and transferred to
Hybond N (Amersham). Hybridization was performed 
with 4 different probes [28]. The complete cDNA 
probe encoding hamster desmin [29] a 1.5-kb EcoRI 
myogenin cDNA fragment and a complete MyoD 
cDNA were labeled according to standard procedures. 
Total RNA amounts were determined by hybridization 
with a ribosomal DNA probe. 
Immunofluorescent staining and Western blotting 
Indirect immunofluorescent staining procedures were 
performed on cultured cells as described previously 
[30]. We used a polyclonal rabbit antibody (poly-des) 
to chicken gizzard muscle desmin [31] and a mono- 
clonal anti-skeletal myosin (fast twitch) antibody (Sig- 
ma). The preparation of cytoskeletal extracts of cul- 
tured cells and one-dimensional SDS-gel et ctrophore- 
sis were described previously [32]. Two Western blots 
containing t2 different ransformed cell lines were 
incubated with a polyclonal antibody to desmin and 
a monoclonal ntibody to large T antigen (kindly pro- 
vided by Dr, van der Eb), both followed by an incu- 
bation with a peroxidase conjugated second antibody 
(Nordic). Bands were visualized by incubation i  phos- 
phate buffered saline (PBS) with 0.6 mg/ml 4-chloro~ 
1-naphtol (solubilized in ethanol) and 0.6 #l/ml of a 
30% H202 solution. The same imnmnodetection pro- 
cedure has also been used for a Western blot containing 
C2 cells and transformed hamster muscle cells grown 
under proliferative and differentiation promoting con- 
ditions. 
Results 
After transformation with the origin-defective SV40 
plasmid we have analyzed 12 rapidly growing cell 
clones for the expression of large T antigen with a 
monoclonal ntibody. The different cell clones express 
various amounts of large T antigen (Fig. 1). The same 
¢~ r~ ~ ~ N ~ ~ Oqk ~! 4 ~ ¢,D 
- r "  '-r- "1- - r "  ~ "-r" "-r- - ' I -  "r = ::1:: "-r'- " r -  
~tq ~ ¢'~ eq ~ ,~ ~14 eq ~t 4 ~ ~ O,i 
1 " 
- ...... < Desmin 
145 
. . . . . . . . . . . . .  < k a r g e T 
antigen 
Fig,. l. Western blot analysis of 12 transformed hamster muscle cell lines, using a monoclonal ntibody directed against SV40 large T antigen 
and a desmin polyclonal ntibody. 
Fig. 2. Phenotype of C2 cells and 4Ha5 cells stained with a desmin 
polyclonal ntibody after culturing under differentiative conditions. 
cell panel has also been tested for desmin expression 
using a polyclonal antibody. High amounts of desmin 
protein have been detected in all cell lines. To induce 
differentiation, cells originating from each of the 12 
different clones and a small cell sample of untransfect- 
ed primary hamster muscle cells, have been switched to 
low mitogen medium, immediately after clonal isola- 
tion. The untransfected hamster cells showed extensive 
differentiation i to myotubes. Occasionally a few elon- 
gated cells with a myombe-like appearance were seen 
in some of the transformed cell clones. However, no 
multinucleated myotube formation could be detected. 
In Fig. 2, cells originating from one of the transformed 
hamster clones are compared with fully differentiated 
C2 myotubes by immunofluorescence staining with a 
polyclonal desmin antibody. Differentiation tests have 
been performed at a very early stage. This means that 
cell clones have been isolated two weeks after transfec- 
tion and immediately split into two cell samples, one 
for expansion and one for the differentiation test. 
Because of the limited lifespan of the primary ham- 
ster muscle ceils we have included the mouse cell line 
C2 as a control cell line in our experiments. Moreover, 
the established mouse muscle cell line C2 is a generally 
accepted model system for muscle cell differentiation 
and this cell line has also been used in comparison with 
fusion-defective muscle cell lines in several other cas- 
es [33, 9]. Fusion of C2 myoblasts into mukinucleated 
myotubes is associated with an elevation of desmin 
expression. Furthermore, C2 cells are known to con- 
tain myogenic diffentiation markers like MyoD and 
myogenin. Myogenin is poorly expressed in undiffer- 
entiated myoblast cells and becomes highly elevated 
in multinucleated myotubes. MyoD is expressed in 
myoblasts and myotubes. Since all cell clones test- 
ed gave similar esults we only show the Northern blot 
analysis of one of the transformed clones in comparison 
with the analysis of C2 myoblasts and myotubes (Fig. 
3A). C2 cells and transformed hamster cells have been 
analyzed for MyoD, myogenin and desmin mRNA. 
Desmin is highly expressed under normal conditions 
(10% fetal bovine serum) and in low serum medium. 
Here, howerever, a two-fold decrease can be observed 
in comparison with the mRNA amounts in cells grown 
under normal conditions. We do not have an explana- 
tion for this phenomenon. As shown in Fig. 3A under 
high and low serum conditions hardly any MyoD and 
myogenin could be detected in the transformed hamster 
cell line. Because we wanted to determine if desmin 
mRNA levels correlate with protein expression, we 
have also performed Western blot analysis with a poly- 
clonal desmin antibody (Fig. 3B). We can conclude 
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Fig. 4. Human fibroblas{s infected with a retrovirus encoding 
MyoD were grown exponentially (10% fetal bovine serum) and 
under differentiation promoting conditions (2% horse serum) and 
incubated with a polyclonal desmin antibody. Desmin-positive cells 
are detected under both culturing conditions. 
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Fig. 3. Northern blot analysis of 4Ha5 and C2 cells grown under 
proliferating (10% fetal bovine serum) and differentiation promoting 
(2% horse serum) conditions (A). Northern blots were hybridized 
with the indicated probes and RNA amounts are approximately qual 
as detected by hybridization with a ribosomal DNA probe (control). 
Cells grown under the same conditions were used for Western blot 
analysis with a monoclonal desmin antibody (B). 
from these experiments hat desmin protein levels are 
very similar in hamster muscle cells cultured in medi- 
um supplemented with 10% fetal bovine serum or 2% 
horse serum, although mRNA levels are approximately 
2-fold lower under low serum conditions. 
To compare the primary conditions for desmin 
expression in different cell types, we have infected 
human fibroblasts with a retrovirus where MyoD cod- 
ing sequences are governed by a viral LTR (long ter- 
minal repeat) promoter. Infected cells can be selected 
because the retroviral DNA also encodes the G418 
resistance gene. In this way up to 30% of the cells 
express MyoD, like has been shown for several non- 
muscle cell types, where retrovirally encoded MyoD 
leads to differentiation along the myogenic lineage [26, 
34]. It is reported earlier that for this differentiation 
step forced expression of MyoD must be followed by 
withdrawal from the cell cycle. We have observed 
desmin expression in cells cultured under prolifera- 
tive and ifferentiative conditions (Fig. 4). Therefore, 
MyoD expression alone is sufficient for induction of 
the desmin gene in cells which are normally desmin- 
negative. 
The retroviral infection procedure has also been 
applied to investigate whether differentiation can pro- 
ceed in fusion-incompetent hamster cells by forced 
expression of MyoD. After selection, the cells 
have been switched to differentiation medium and 
immunofluorescence tests have been performed for 
the detection of the terminal differentiation marker 
fast-twitch skeletal myosin. We have never observed 
myotube-like cells after infection with the MyoD- 
encoding virus followed by selection by geneticin and 
either no myosin protein could be detected in selected 
hamster muscle cells. On the other hand in differentiat- 
ed C2 myotubes myosin expression was clearly visible 
(results not shown). This indicates that desmin can be 
expressed independent of the expression of MyoD and 
myogenin. The large T antigen block can, in this case, 
not be bypassed by re-expression of MyoD. 
Discussion 
We have shown that primary muscle satellite cells 
transfected with the transcription unit of SV40 large 
T antigen do not conform to terminal differentiation 
anymore. Previous reports largely describe the trans- 
fection of established muscle cell lines with transform- 
ing genes such as ras, jun, myc and E1A [10, 12, 11, 
35]. All our isolated cell clones were growing expo- 
nentially and continued to express desmin. We have 
performed Northern blot analysis with a few clones for 
detection of MyoD and myogenin mRNA expression. 
Although desmin expression levels were comparable 
in C2 muscle cells and transformed hamster cells, no 
MyoD and myogenin mRNA could be detected. 
Activated Ras and excess Fos have been shown 
to prevent terminal differentiation [10], by interfering 
with MyoD expression. Another possible mechanism 
is provided by the direct interaction of MyoD with the 
l eucine zipper of c-Jun. In the case of excess c-Jun, cell 
growth is favored instead of cellular differentiation. 
Recently new information i  this respect has been pro- 
vided by experiments concerning the retinoblastoma 
gene product. This protein in its unphosphorylated 
form is proven to be important for withdrawal from 
the cell cycle during myogenesis [36]. Cell cycle with- 
drawal can be prevented by binding of the SV40 large T 
antigen to the retinoblastoma protein. Although MyoD 
also has the ability to cause growth arrest upon expres- 
sion in cell lines transformed by oncogenes [37], the 
SV40 large T antigen demonstrates a dominant effect 
over MyoD by reversing the cell cycle block. 
The absence of MyoD and myogenin may con- 
tribute to the lack of differentiation i  our transformed 
hamster muscle cells. There are indications that MyoD 
may be more important in this respect because BC3H1 
cells, which do express myogenin but no MyoD, are 
fusion incompetent. In this case the block can be over- 
come by exogenous expression of MyoD [33]. Retro- 
virally encoded MyoD cannot induce terminal differ- 
entiation in our transformed muscle cells. This means 
that inhibition of terminal differentiation by activated 
Ras and by overexpressed Fos operates via a differ- 
ent mechanism. This conclusion can be drawn because 
MyoD expression did result in re-expression of mark- 
ers associated with terminal differentiation i  the case 
of Ras and Fos [10]. 
The above evidence indicates that desmin expres- 
sion is not totally dependent on the expression of MyoD 
and myogenin. Cells in a highly proliferative state, 
represented by the transformation with large T anti- 
gen, are still able to express the early differentiation 
marker desmin. This is in agreement with the results 
obtained with the MyoD-infected fibroblasts where 
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desmin expression can be detected in cells cuttured 
in high mitogen medium. 
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